In colorectal cancer, it was shown that the activity of BAF-occupied enhancers is reduced in ARID1A-deficient cells and accompanied by a loss of the active H3K27ac mark (acetylation of lysine 27 on histone 3) [21]. Here, ARID1A is linked to colorectal cancer.